Lutein and Zeaxanthin, graded Strong-evidence on Magellan — for cognition, one trial in younger adults found improved complex attention and flexibility, but in AREDS2's older participants with macular degeneration cognition did not improve—so this is an AMD-risk-management nutrient pair, not a general vision or anti-aging enhancer.
Source: Arch Biochem Biophys 2018, PMID 29885291 ↗ · Nutraceuticals & Cellular Energizers · How Magellan grades evidence · Study write-up · evidence confidence: high
Lutein and zeaxanthin are xanthophyll carotenoids—yellow-to-orange plant pigments obtained from the diet (notably dark leafy greens, egg yolks, and yellow/orange produce) that the human body cannot synthesize. They are selectively concentrated in the macula of the retina, where together with meso-zeaxanthin they form the macular pigment, and are also deposited in the brain and lens. Acting as antioxidants and blue-light filters, they neutralize reactive oxygen species and absorb high-energy visible light, functions thought to protect the retina and neural tissue from oxidative and photic stress.
The best human evidence concerns eye health in aging: in the landmark AREDS2 randomized trial, adding lutein/zeaxanthin to the AREDS formula missed its primary endpoint, but ten-year follow-up found the pair reduced progression to late disease and proved a safe replacement for beta-carotene, which nearly doubled lung-cancer risk in former smokers. A 2023 Cochrane review confirms these supplements slow progression in people who already have the disease but do not prevent it in healthy eyes, and a post-hoc analysis found slowed geographic-atrophy growth toward the fovea. Trials also show improved macular pigment density, visual acuity, and contrast sensitivity. For cognition, one trial in younger adults found improved complex attention and flexibility, but in AREDS2's older participants with macular degeneration cognition did not improve—so this is an AMD-risk-management nutrient pair, not a general vision or anti-aging enhancer. This evidence describes the carotenoids and their mechanisms as studied in the literature, not this specific commercial product.
Peer-reviewed studies on the active compound — citations link to PubMed.
“carotenoids also produce improvements in cognitive function and cardiovascular health”
“improved cognitive performance (focus, episodic memory and learning, visuospatial working memory)”
“Supplementation with L + Z improves CNS xanthophyll levels and cognitive function in young, healthy adults”
“Addition of lutein + zeaxanthin, DHA + EPA, or both to the AREDS formulation in primary analyses did not further reduce risk of progression to advanced AMD. However, because of potential increased incidence of lung cancer in former smokers, lutein + zeaxanthin could be an appropriate carotenoid substitute in the AREDS formulation.”
“A direct analysis of lutein/zeaxanthin vs beta carotene showed the HR for late AMD was 0.85 (95% CI, 0.73-0.98; P = .02).”
“Oral micronutrient supplementation slowed GA progression toward the central macula, likely by augmenting the natural phenomenon of foveal sparing.”
Research describes the active mechanism and is not a claim about this specific product.
Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum…
Across meta-analyses and randomized trials, creatine monohydrate combined with…
In humans, randomized trials and meta-analyses most consistently show that astaxanthin…
Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after…
Yes — its active compound is linked to 21 peer-reviewed studies, summarized and cited above.
You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.
Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.